Risk Factors Update Summary
- Repayment of certain convertible notes, if not converted, requires a significant cash amount. This might strain cash flow.
- Shareholders face substantial dilution due to issued convertible notes and options. Over 6.5 million shares at $29.50.
- The company had an accumulated deficit increase from approximately $219 million to $225 million.
- Cash and cash equivalents decreased from approximately $13.4 million to $8.4 million.
- The company expects to spend approximately $5 million in 2024 for product development.
- The company's stock price fluctuated between $7.00 and $65.00 per share in 2023.
- Failure to meet Nasdaq listing requirements could lead to delisting, impacting liquidity and financing.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=812796&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.